World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
55
Citations
10012
World Ranking
12210
National Ranking
7

Stanislav Gobec publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Stanislav Gobec sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 446 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Stanislav Gobec D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stanislav Gobec sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 55 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Stanislav Gobec is affiliated with the University of Ljubljana in Slovenia and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields, including Molecular Biology, Pharmacology, Organic Chemistry, Computational Theory and Mathematics, and Oncology. This multidisciplinary approach supports their focus on various complex biological and chemical challenges within medical science.

The scientific topics Stanislav Gobec has explored include:

  • Cholinesterase and Neurodegenerative Diseases
  • Computational Drug Discovery Methods
  • Peptidase Inhibition and Analysis
  • Chemical Synthesis and Analysis
  • Alzheimer's Disease Research and Treatments
  • Click Chemistry and Applications
  • Medicinal Plants and Neuroprotection

Stanislav Gobec's publication record shows significant contributions to several scientific journals. Frequent venues where their work appears include:

  • European Journal of Medicinal Chemistry
  • ACS Omega
  • Biomedicine & Pharmacotherapy
  • Molecules
  • Bioorganic Chemistry

Some recent papers authored by Stanislav Gobec are:

  • Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets (2020) - Pharmacology & Therapeutics
  • Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discovery (2022) - Biomedicine & Pharmacotherapy
  • N-alkylpiperidine carbamates as potential anti-Alzheimer's agents (2020) - European Journal of Medicinal Chemistry
  • Stereoselective Activity of 1-Propargyl-4-styrylpiperidine-like Analogues That Can Discriminate between Monoamine Oxidase Isoforms A and B (2020) - Journal of Medicinal Chemistry
  • Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview (2021) - Pharmaceutics

The scientist frequently collaborates with a set of coauthors. The most common collaborators include:

  • Damijan Knez
  • Izidor Sosič
  • Matic Proj
  • Janko Kos
  • Xavier Brazzolotto

Stanislav Gobec has been recognized with the title of Member of the European Academy of Sciences and Arts.

Best Publications

  • Cytoplasmic steps of peptidoglycan biosynthesis.

    Hélène Barreteau;Andreja Kovač;Audrey Boniface;Matej Sova

  • Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

    Boris Brus;Urban Košak;Samo Turk;Anja Pišlar

  • Inhibitors of Cathepsin B

    Frlan R;Gobec S

  • Development of an in-vivo active reversible butyrylcholinesterase inhibitor

    Urban Košak;Boris Brus;Damijan Knez;Roman Šink

  • The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

    Urban Košak;Boris Brus;Damijan Knez;Simon Žakelj

  • Endocrine Disruptome—An Open Source Prediction Tool for Assessing Endocrine Disruption Potential through Nuclear Receptor Binding

    Katra Kolšek;Janez Mavri;Marija Sollner Dolenc;Stanislav Gobec

  • False Positives in the Early Stages of Drug Discovery

    Roman Sink;Stanislav Gobec;Slavko Pečar;Anamarija Zega

  • A road map for prioritizing warheads for cysteine targeting covalent inhibitors.

    Péter Ábrányi-Balogh;László Petri;Tímea Imre;Péter Szijj

  • Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase.

    Nace Zidar;Tihomir Tomašić;Roman Šink;Veronika Rupnik

  • Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F

    Martina Hrast;Izidor Sosič;Roman Šink;Stanislav Gobec

  • Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.

    Dawid Panek;Anna Więckowska;Tomasz Wichur;Marek Bajda

  • Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1

    S. Gobec;P. Brozic;T. Lanisnik Rizner

  • Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity†

    Martina Gobec;Jakob Kljun;Izidor Sosič;Irena Mlinarič-Raščan

  • Novel Mechanism of Cathepsin B Inhibition by Antibiotic Nitroxoline and Related Compounds

    Bojana Mirković;Miha Renko;Samo Turk;Izidor Sosič

  • Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4-hydroxylase (CYP53).

    B. Korošec;M. Sova;S. Turk;N. Kraševec

  • Structural and Functional Characterization of Enantiomeric Glutamic Acid Derivatives as Potential Transition State Analogue Inhibitors of Murd Ligase.

    Miha Kotnik;Jan Humljan;Carlos Contreras-Martel;Marko Oblak

  • LiSiCA: A Software for Ligand-Based Virtual Screening and Its Application for the Discovery of Butyrylcholinesterase Inhibitors.

    Samo Lešnik;Tanja Štular;Boris Brus;Damijan Knez

  • Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.

    Damijan Knez;Nicolas Coquelle;Anja Pišlar;Simon Žakelj

  • Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis.

    Roman Šink;Izidor Sosič;Matej Živec;Raquel Fernandez-Menendez

  • 5‐Benzylidenethiazolidin‐4‐ones as Multitarget Inhibitors of Bacterial Mur Ligases

    Tihomir Tomašić;Nace Zidar;Andreja Kovač;Samo Turk

  • Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties

    Natalia Guzior;Marek Bajda;Mirosław Skrok;Katarzyna Kurpiewska

  • Antibacterial and β‐Lactamase Inhibitory Activity of Monocyclic β‐Lactams

    Lena Decuyper;Marko Jukič;Izidor Sosič;Aleš Žula

  • Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme.

    Jan Humljan;Miha Kotnik;Carlos Contreras-Martel;Didier Blanot

Frequent Co-Authors

Didier Blanot
Didier Blanot University of Paris-Saclay
Janko Kos
Janko Kos University of Ljubljana
Andréa Dessen
Andréa Dessen Brazilian Biosciences National Laboratory
Bernard Joris
Bernard Joris University of Liège
Dominique Mengin-Lecreulx
Dominique Mengin-Lecreulx University of Paris-Saclay
Florian Nachon
Florian Nachon Centre national de la recherche scientifique, CNRS
Ian Chopra
Ian Chopra University of Leeds
Gerhard Wolber
Gerhard Wolber Freie Universität Berlin
Alex J. O'Neill
Alex J. O'Neill University of Leeds
Christopher G. Dowson
Christopher G. Dowson University of Warwick

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Chemistry in the USA, exploring related fields like forensic science can open diverse career opportunities. Those interested in practical applications of chemical analysis in death investigations might consider learning how to become an autopsy technician. This role requires a strong foundation in biology and chemistry, offering a vital position in medical examinations.

Many universities now offer online forensic science courses to accommodate working professionals or remote learners. These programs combine chemistry with law enforcement and often serve as stepping stones to advanced studies or specialized roles within forensic labs.

If your interest leans towards the intersection of psychology and forensic investigation, consider exploring forensic psychology master’s programs. These degrees prepare graduates for careers that analyze criminal behavior alongside chemical evidence, further broadening job prospects.

Understanding the financial outlook is crucial when selecting a career path. Information about forensic science degree salary helps students evaluate the return on investment and plan their educational journey accordingly.

Best Scientists Citing Stanislav Gobec

Trending Scientists

Recently Published Articles